European Enzyme Immunoassay(EIA) MARKET By Type, By Technique, By End User (Hospital Laboratories, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Academics, Blood Banks) Analysis and Forecast to 2020
The report analyzes the European enzyme immunoassay (EIA) Market by type, technique, end-user, and by country. The European enzyme immunoassay (EIA) market has been classified on the basis of types which mainly includes; EIA reagents & kits, and EIA analyzers. On the basis of technique the market is divided into; ELISA, rapid tests, and ELISPOT.
Germany is the largest contributor to the European enzyme immunoassay (EIA) market, basically due to the rising incidences of chronic and infectious diseases, expanding pharmaceutical and biotechnology industries, and growing use of EIA in oncology. Germany is followed by U.K., and France.
Enzyme immunoassays are widely used in the diagnosis of and research of HIV/AIDS and cancer, owing to which the increasing prevalence of HIV/AIDS and cancer in Europe will drive market growth in the region. According to WHO, the number of HIV patients in Europe increased from ~120,000 in 2011 to ~180,000 in 2012. Furthermore, according to the International Agency for Research on Cancer (IARC), approximately 3.45 million new cancer cases (excluding non-melanoma skin cancer) were reported in Europe in 2012; the prevalence is expected to grow further in the coming years.
In-depth Market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, Annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the key market players of the European enzyme immunoassay (EIA) market include Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), bioMérieux SA (France), Siemens Healthcare GmbH (Germany), Alere (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.) and others.
Germany is the largest contributor to the European enzyme immunoassay (EIA) market, basically due to the rising incidences of chronic and infectious diseases, expanding pharmaceutical and biotechnology industries, and growing use of EIA in oncology. Germany is followed by U.K., and France.
Enzyme immunoassays are widely used in the diagnosis of and research of HIV/AIDS and cancer, owing to which the increasing prevalence of HIV/AIDS and cancer in Europe will drive market growth in the region. According to WHO, the number of HIV patients in Europe increased from ~120,000 in 2011 to ~180,000 in 2012. Furthermore, according to the International Agency for Research on Cancer (IARC), approximately 3.45 million new cancer cases (excluding non-melanoma skin cancer) were reported in Europe in 2012; the prevalence is expected to grow further in the coming years.
In-depth Market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, Annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the key market players of the European enzyme immunoassay (EIA) market include Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), bioMérieux SA (France), Siemens Healthcare GmbH (Germany), Alere (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.) and others.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE ENZYME IMMUNOASSAY (EIA) MARKET
2.2 ARRIVING AT THE ENZYME IMMUNOASSAY (EIA) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 MACRO INDICATOR- BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DRIVERS AND INHIBITORS
5 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, TYPE/TECHNIQUE
5.1 INTRODUCTION
5.2 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
5.3 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
5.3.1 EUROPE ELISA MARKET, BY TYPE OF GENERATION
5.3.2 EUROPE ELISA MARKET, BY PLATFORM
6 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER
6.1 INTRODUCTION
6.2 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
6.3 EUROPE ELISA MARKET, BY END USER
6.4 EUROPE RAPID TESTS MARKET, BY END USER
6.5 EUROPE ELISPOT MARKET, BY END USER
7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY
7.1 INTRODUCTION
7.2 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET
7.2.1 GERMANY ENZYME IMMUNOASSAY MARKET, BY TYPE
7.2.2 GERMANY ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE
7.2.2.1 GERMANY ELISA MARKET,BY TYPEOF GENERATION
7.2.2.2 GERMANY ELISA MARKET,BY PLATFORM
7.2.3 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.2.3.1 GERMANY ELISA MARKET, BY END USER
7.2.3.2 GERMANY RAPID TEST MARKET, BY END USER
7.2.3.3 GERMANY ELISPOT MARKET, BY END USER
7.3 U.K. ENZYME IMMUNOASSAY (EIA) MARKET
7.3.1 U.K. ENZYME IMMUNOASSAY MARKET, BY TYPE
7.3.2 U.K. ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE
7.3.2.1 U.K. ELISA MARKET,BY TYPEOF GENERATION
7.3.2.2 U.K. ELISA MARKET,BY PLATFORM
7.3.3 U.K. ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.3.3.1 U.K. ELISA MARKET, BY END USER
7.3.3.2 U.K. RAPID TEST MARKET, BY END USER
7.3.3.3 U.K. ELISPOT MARKET, BY END USER
7.4 FRANCE ENZYME IMMUNOASSAY (EIA) MARKET
7.4.1 FRANCE ENZYME IMMUNOASSAY MARKET, BY TYPE
7.4.2 FRANCE ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE
7.4.2.1 FRANCE ELISA MARKET,BY TYPE OF GENERATION
7.4.2.2 FRANCE ELISA MARKET,BY PLATFORM
7.4.3 FRANCE ENZYME IMMUNOASSAY MARKET, BY END USER
7.4.3.1 FRANCE ELISA MARKET, BY END USER
7.4.3.2 FRANCE RAPID TEST MARKET, BY END USER
7.4.3.3 FRANCE ELISPOT MARKET, BY END USER
7.5 ITALY ENZYME IMMUNOASSAY (EIA) MARKET
7.5.1 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.5.2 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.5.2.1 ITALY ELISA MARKET, BY TYPE OF GENERATION
7.5.2.2 ITALY ELISA MARKET, BY PLATFORM
7.5.3 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER
7.5.3.1 ITALY ELISA MARKET, BY END USER
7.5.3.2 ITALY RAPID TESTS MARKET, BY END USER
7.5.3.3 ITALY ELISPOT TESTS MARKET, BY END USER
7.6 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET
7.6.1 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.6.2 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.6.2.1 BENELUX ELISA MARKET, BY TYPEOF GENERATION
7.6.2.2 BENELUX ELISA MARKET, BY PLATFORM
7.6.3 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.6.3.1 BENELUX ELISA MARKET, BY END USER
7.6.3.2 BENELUX RAPID TESTS MARKET, BY END USER
7.6.3.3 BENELUX ELISPOT TESTS MARKET, BY END USER
7.7 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET
7.7.1 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.7.2 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.7.2.1 SCANDANAVIA ELISA MARKET, BY TYPEOF GENERATION
7.7.2.2 SCANDANAVIA ELISA MARKET, BY PLATFORM
7.7.3 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.7.3.1 SCANDANAVIA ELISA MARKET, BY END USER
7.7.3.2 SCANDANAVIA RAPID TESTS MARKET, BY END USER
7.7.3.3 SCANDANAVIA ELISPOT TESTS MARKET, BY END USER
7.8 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET
7.8.1 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.8.2 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.8.2.1 SPAIN ELISA MARKET, BY TYPEOF GNERATION
7.8.2.2 SPAIN ELISA MARKET, BY PLATFORM
7.8.3 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.8.3.1 SPAIN ELISA MARKET, BY END USER
7.8.3.2 SPAIN RAPID TESTS MARKET, BY END USER
7.8.3.3 SPAIN ELISPOT TESTS MARKET, BY END USER
8 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET: COMPETITIVE LANDSCAPE
8.1 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS
9 EUROPE ENZYME IMMUNO ASSAY (EIA) MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
9.2 SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG)
9.3 ABBOTT LABORATORIES, INC.
9.4 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION)
9.5 ORTHO-CLINICAL DIAGNOSTICS, INC.
9.6 BECTON, DICKINSON AND COMPANY
9.7 BIOMÉRIEUX SA
9.8 BIO-RAD LABORATORIES, INC.
9.9 ALERE, INC.
9.10 SYSMEX CORPORATION
9.11 DIASORIN S.P.A.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CUSTOMIZATION OPTIONS
10.1.1 PRODUCT ANALYSIS
10.1.2 BRAND/PRODUCT PERCEPTION MATRIX
10.1.3 PORTER’S FIVE FORCES ANALYSIS
10.2 RT SNAPSHOT
10.3 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE ENZYME IMMUNOASSAY (EIA) MARKET
2.2 ARRIVING AT THE ENZYME IMMUNOASSAY (EIA) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 MACRO INDICATOR- BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DRIVERS AND INHIBITORS
5 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, TYPE/TECHNIQUE
5.1 INTRODUCTION
5.2 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
5.3 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
5.3.1 EUROPE ELISA MARKET, BY TYPE OF GENERATION
5.3.2 EUROPE ELISA MARKET, BY PLATFORM
6 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER
6.1 INTRODUCTION
6.2 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
6.3 EUROPE ELISA MARKET, BY END USER
6.4 EUROPE RAPID TESTS MARKET, BY END USER
6.5 EUROPE ELISPOT MARKET, BY END USER
7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY
7.1 INTRODUCTION
7.2 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET
7.2.1 GERMANY ENZYME IMMUNOASSAY MARKET, BY TYPE
7.2.2 GERMANY ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE
7.2.2.1 GERMANY ELISA MARKET,BY TYPEOF GENERATION
7.2.2.2 GERMANY ELISA MARKET,BY PLATFORM
7.2.3 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.2.3.1 GERMANY ELISA MARKET, BY END USER
7.2.3.2 GERMANY RAPID TEST MARKET, BY END USER
7.2.3.3 GERMANY ELISPOT MARKET, BY END USER
7.3 U.K. ENZYME IMMUNOASSAY (EIA) MARKET
7.3.1 U.K. ENZYME IMMUNOASSAY MARKET, BY TYPE
7.3.2 U.K. ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE
7.3.2.1 U.K. ELISA MARKET,BY TYPEOF GENERATION
7.3.2.2 U.K. ELISA MARKET,BY PLATFORM
7.3.3 U.K. ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.3.3.1 U.K. ELISA MARKET, BY END USER
7.3.3.2 U.K. RAPID TEST MARKET, BY END USER
7.3.3.3 U.K. ELISPOT MARKET, BY END USER
7.4 FRANCE ENZYME IMMUNOASSAY (EIA) MARKET
7.4.1 FRANCE ENZYME IMMUNOASSAY MARKET, BY TYPE
7.4.2 FRANCE ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE
7.4.2.1 FRANCE ELISA MARKET,BY TYPE OF GENERATION
7.4.2.2 FRANCE ELISA MARKET,BY PLATFORM
7.4.3 FRANCE ENZYME IMMUNOASSAY MARKET, BY END USER
7.4.3.1 FRANCE ELISA MARKET, BY END USER
7.4.3.2 FRANCE RAPID TEST MARKET, BY END USER
7.4.3.3 FRANCE ELISPOT MARKET, BY END USER
7.5 ITALY ENZYME IMMUNOASSAY (EIA) MARKET
7.5.1 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.5.2 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.5.2.1 ITALY ELISA MARKET, BY TYPE OF GENERATION
7.5.2.2 ITALY ELISA MARKET, BY PLATFORM
7.5.3 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER
7.5.3.1 ITALY ELISA MARKET, BY END USER
7.5.3.2 ITALY RAPID TESTS MARKET, BY END USER
7.5.3.3 ITALY ELISPOT TESTS MARKET, BY END USER
7.6 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET
7.6.1 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.6.2 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.6.2.1 BENELUX ELISA MARKET, BY TYPEOF GENERATION
7.6.2.2 BENELUX ELISA MARKET, BY PLATFORM
7.6.3 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.6.3.1 BENELUX ELISA MARKET, BY END USER
7.6.3.2 BENELUX RAPID TESTS MARKET, BY END USER
7.6.3.3 BENELUX ELISPOT TESTS MARKET, BY END USER
7.7 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET
7.7.1 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.7.2 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.7.2.1 SCANDANAVIA ELISA MARKET, BY TYPEOF GENERATION
7.7.2.2 SCANDANAVIA ELISA MARKET, BY PLATFORM
7.7.3 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.7.3.1 SCANDANAVIA ELISA MARKET, BY END USER
7.7.3.2 SCANDANAVIA RAPID TESTS MARKET, BY END USER
7.7.3.3 SCANDANAVIA ELISPOT TESTS MARKET, BY END USER
7.8 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET
7.8.1 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE
7.8.2 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE
7.8.2.1 SPAIN ELISA MARKET, BY TYPEOF GNERATION
7.8.2.2 SPAIN ELISA MARKET, BY PLATFORM
7.8.3 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER
7.8.3.1 SPAIN ELISA MARKET, BY END USER
7.8.3.2 SPAIN RAPID TESTS MARKET, BY END USER
7.8.3.3 SPAIN ELISPOT TESTS MARKET, BY END USER
8 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET: COMPETITIVE LANDSCAPE
8.1 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS
9 EUROPE ENZYME IMMUNO ASSAY (EIA) MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
9.2 SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG)
9.3 ABBOTT LABORATORIES, INC.
9.4 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION)
9.5 ORTHO-CLINICAL DIAGNOSTICS, INC.
9.6 BECTON, DICKINSON AND COMPANY
9.7 BIOMÉRIEUX SA
9.8 BIO-RAD LABORATORIES, INC.
9.9 ALERE, INC.
9.10 SYSMEX CORPORATION
9.11 DIASORIN S.P.A.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CUSTOMIZATION OPTIONS
10.1.1 PRODUCT ANALYSIS
10.1.2 BRAND/PRODUCT PERCEPTION MATRIX
10.1.3 PORTER’S FIVE FORCES ANALYSIS
10.2 RT SNAPSHOT
10.3 RELATED REPORTS
LIST OF TABLES
Table 1 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MN)
Table 2 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MN)
Table 3 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER, 2013-2020 (USD MN)
Table 4 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY COUNTRY, 2013-2020 (USD MN)
Table 5 ENZYME IMMUNOASSAY (EIA) MARKET: DRIVERS AND INHIBITORS
Table 6 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECNIQUES, 2013–2020 (USD MILLION)
Table 8 EUROPE ENZYMEIMMUNOASSAY (EIA) MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 9 EUROPE ENZYMEIMMUNOASSAY (EIA) MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 10 EUROPE ENZYME IMMUNOASSAY MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 11 EUROPE ELISA MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 12 EUROPE RAPID TESTS MARKET, BY END-USER, 2013–2020 (USD MILLION)
Table 13 EUROPE ELISPOT MARKET, BY END-USER, 2013–2020 (USD MILLION)
Table 14 GERMANY EIA MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 15 GERMANY ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 16 GERMANY ELISA MARKET, BY TYPE OF GENERATION, 2013-2020 (USD MILLION)
Table 17 GERMANY ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
Table 18 GERMANY EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 19 GERMANY ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 20 GERMANY RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 21 GERMANY ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 22 U.K. ENZYME IMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 23 U.K. ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 24 U.K. ELISA MARKET, BY TYPE OF GENERATION, 2013-2020 (USD MILLION)
Table 25 U.K. ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
Table 26 U.K. EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 27 U.K. ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 28 U.K. RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 29 U.K. ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 30 FRANCE ENZYME IMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 31 FRANCE ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 32 FRANCE ELISA MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 33 FRANCE ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
Table 34 FRANCE EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 35 FRANCE ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 36 FRANCE RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 37 FRANCE ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 38 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 39 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 40 ITALY ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 41 ITALY ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 42 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 43 ITALY ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 44 ITALY RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 45 ITALY ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 46 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 47 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 48 BENELUX ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 49 BENELUX ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 50 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 51 BENELUX ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 52 BENELUX RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 53 BENELUX ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 54 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 55 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 56 SCANDANAVIA ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 57 SCANDANAVIA ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 58 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 59 SCANDANAVIA ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 60 SCANDANAVIA RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 61 SCANDANAVIA ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 62 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 63 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 64 SPAIN ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 65 SPAIN ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 66 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 67 SPAIN ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 68 SPAIN RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 69 SPAIN ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 70 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 1 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MN)
Table 2 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MN)
Table 3 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER, 2013-2020 (USD MN)
Table 4 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY COUNTRY, 2013-2020 (USD MN)
Table 5 ENZYME IMMUNOASSAY (EIA) MARKET: DRIVERS AND INHIBITORS
Table 6 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECNIQUES, 2013–2020 (USD MILLION)
Table 8 EUROPE ENZYMEIMMUNOASSAY (EIA) MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 9 EUROPE ENZYMEIMMUNOASSAY (EIA) MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 10 EUROPE ENZYME IMMUNOASSAY MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 11 EUROPE ELISA MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 12 EUROPE RAPID TESTS MARKET, BY END-USER, 2013–2020 (USD MILLION)
Table 13 EUROPE ELISPOT MARKET, BY END-USER, 2013–2020 (USD MILLION)
Table 14 GERMANY EIA MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 15 GERMANY ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 16 GERMANY ELISA MARKET, BY TYPE OF GENERATION, 2013-2020 (USD MILLION)
Table 17 GERMANY ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
Table 18 GERMANY EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 19 GERMANY ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 20 GERMANY RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 21 GERMANY ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 22 U.K. ENZYME IMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 23 U.K. ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 24 U.K. ELISA MARKET, BY TYPE OF GENERATION, 2013-2020 (USD MILLION)
Table 25 U.K. ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
Table 26 U.K. EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 27 U.K. ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 28 U.K. RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 29 U.K. ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 30 FRANCE ENZYME IMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 31 FRANCE ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 32 FRANCE ELISA MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 33 FRANCE ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
Table 34 FRANCE EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 35 FRANCE ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 36 FRANCE RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 37 FRANCE ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 38 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 39 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 40 ITALY ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 41 ITALY ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 42 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 43 ITALY ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 44 ITALY RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 45 ITALY ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 46 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 47 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 48 BENELUX ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 49 BENELUX ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 50 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 51 BENELUX ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 52 BENELUX RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 53 BENELUX ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 54 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 55 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 56 SCANDANAVIA ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 57 SCANDANAVIA ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 58 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 59 SCANDANAVIA ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 60 SCANDANAVIA RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 61 SCANDANAVIA ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 62 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 63 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
Table 64 SPAIN ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Table 65 SPAIN ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Table 66 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 67 SPAIN ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 68 SPAIN RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 69 SPAIN ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
Table 70 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
LIST OF FIGURES
Figure 1 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET SEGMENTATION & COVERAGE
Figure 2 ENZYME IMMUNOASSAY (EIA) MARKET: INTEGRATED ECOSYSTEM
Figure 3 ARRIVING AT THE ENZYME IMMUNOASSAY (EIA) MARKET SIZE
Figure 4 TOP-DOWN APPROACH
Figure 5 MACRO INDICATOR-BASED APPROACH
Figure 6 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET SNAPSHOT
Figure 7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013–2020 (USD MILLION)
Figure 8 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013–2020 (USD MILLION)
Figure 9 EUROPE ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Figure 10 EUROPE ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Figure 11 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 12 EUROPE ELISA MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 13 EUROPE RAPID TESTS MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 14 EUROPE ELISPOT MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 15 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 16 U.K. ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 17 FRANCE ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 18 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 19 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 20 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 21 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 22 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 23 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.): REVEUE MIX, 2014 (%)
Figure 24 SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG) REVENUE MIX, 2014 (%)
Figure 25 ABBOTT LABORATORIES, INC. REVENUE MIX, 2014 (%)
Figure 26 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION) REVENUE MIX, 2013 (%)
Figure 27 BECTON, DICKINSON AND COMPANY: REVENUE MIX 2014 (%)
Figure 28 BIOMÉRIEUX SA: REVENUE MIX 2014 (%)
Figure 29 BIO-RAD LABORATORIES, INC.: REVENUE MIX 2014 (%)
Figure 30 SYSMEX CORPORATION BUSINESS SERVICES, LLC: REVENUE MIX 2014 (%)
Figure 31 DIASORIN S.P.A: GEOGRAPHICAL AND BUSINESS REVENUE MIX 2014(%)
Figure 1 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET SEGMENTATION & COVERAGE
Figure 2 ENZYME IMMUNOASSAY (EIA) MARKET: INTEGRATED ECOSYSTEM
Figure 3 ARRIVING AT THE ENZYME IMMUNOASSAY (EIA) MARKET SIZE
Figure 4 TOP-DOWN APPROACH
Figure 5 MACRO INDICATOR-BASED APPROACH
Figure 6 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET SNAPSHOT
Figure 7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013–2020 (USD MILLION)
Figure 8 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013–2020 (USD MILLION)
Figure 9 EUROPE ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
Figure 10 EUROPE ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
Figure 11 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 12 EUROPE ELISA MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 13 EUROPE RAPID TESTS MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 14 EUROPE ELISPOT MARKET, BY END-USER, 2013–2020 (USD MILLION)
Figure 15 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 16 U.K. ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 17 FRANCE ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 18 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 19 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 20 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 21 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
Figure 22 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 23 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.): REVEUE MIX, 2014 (%)
Figure 24 SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG) REVENUE MIX, 2014 (%)
Figure 25 ABBOTT LABORATORIES, INC. REVENUE MIX, 2014 (%)
Figure 26 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION) REVENUE MIX, 2013 (%)
Figure 27 BECTON, DICKINSON AND COMPANY: REVENUE MIX 2014 (%)
Figure 28 BIOMÉRIEUX SA: REVENUE MIX 2014 (%)
Figure 29 BIO-RAD LABORATORIES, INC.: REVENUE MIX 2014 (%)
Figure 30 SYSMEX CORPORATION BUSINESS SERVICES, LLC: REVENUE MIX 2014 (%)
Figure 31 DIASORIN S.P.A: GEOGRAPHICAL AND BUSINESS REVENUE MIX 2014(%)
